#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4006	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1994	387.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1396	1396	C	488	C	318	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8410	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3869	421.2	0	.	n	.	0	T695C	SNP	695	695	T	1218	1218	C	586	C,T	361,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8410	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3869	421.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1860	1860	A	494	A,C	325,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8410	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3869	421.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2494	2494	C	486	C,A	309,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8410	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3869	421.2	0	.	n	.	0	C2403T	SNP	2403	2403	C	2926	2926	T	515	T,C	250,96	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8410	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3869	421.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2568	2568	A	463	A	298	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8410	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3869	421.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3120	3120	C	571	C,A,T	384,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	632	folP	855	855	100.0	folP.l15.c4.ctg.1	1734	72.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1125	1127	AGC	130;130;128	A;G;C	84;84;83	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1400	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3471	78.5	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	105;105;105	T;T;C	72;71;72	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1400	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3471	78.5	1	SNP	p	D95G	1	.	.	283	285	GGC	595	597	GGC	109;111;111	G;G;C	75;75;75	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1400	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3471	78.5	1	SNP	p	G95N	0	.	.	283	285	GGC	595	597	GGC	109;111;111	G;G;C	75;75;75	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	500	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1326	76.8	1	SNP	p	G45D	0	.	.	133	135	GGC	464	466	GGC	152;154;152	G;G;C	94;95;94	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	382	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	966	74.3	0	.	n	.	0	A197.	DEL	197	197	A	641	641	A	178	A	112	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2996	88.9	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	132;132;135	G;A;C	82;79;84	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2996	88.9	1	SNP	p	R87W	0	.	.	259	261	CGT	596	598	CGT	138;139;139	C;G;T,G	89;90;90,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2996	88.9	1	SNP	p	R87I	0	.	.	259	261	CGT	596	598	CGT	138;139;139	C;G;T,G	89;90;90,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2996	88.9	1	SNP	p	S87R	1	.	.	259	261	CGT	596	598	CGT	138;139;139	C;G;T,G	89;90;90,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2996	88.9	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	139;140;141	T;C;C	92;92;93	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	C38G	NONSYN	112	114	TGC	1024	1026	TGC	104;106;110	T,G;G;C	70,1;73;75	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	V41F	NONSYN	121	123	GTC	1033	1035	GTC	108;105;105	G,T;T;C	73,1;72;72	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	A45G	NONSYN	133	135	GCG	1045	1047	GCG	95;94;96	G;C,G;G	63;60,1;65	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	A46G	NONSYN	136	138	GCG	1048	1050	GCG	96;95;97	G;C,G,A;G	63;62,2,1;66	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	D47N	NONSYN	139	141	GAC	1051	1053	GAC	99;99;98	G,A,T;A;C	64,2,1;67;65	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	A49G	NONSYN	145	147	GCG	1057	1059	GCG	99;99;99	G;C,G;G	66;65,1;69	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	L50W	NONSYN	148	150	TTG	1060	1062	TTG	99;99;100	T;T;G	69;66;67	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	I57M	NONSYN	169	171	ATC	1081	1083	ATC	105;103;103	A,C,G;T,G;C	68,1,1;64,1;67	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	D58V	NONSYN	172	174	GAC	1084	1086	GAC	103;103;103	G,A;A,C,T;C,G	68,2;67,2,1;68,2	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	D64E	NONSYN	190	192	GAC	1102	1104	GAC	100;98;99	G;A,T,G,C;C,T,G,A	68;63,1,1,1;63,1,2,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	N72S	NONSYN	214	216	AAC	1126	1128	AAC	94;94;94	A,C;A;C	63,1;57;55	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	G79A	NONSYN	235	237	GGC	1147	1149	GGC	98;99;100	G,C;G,C;C	67,1;63,1;71	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	L80R	NONSYN	238	240	CTG	1150	1152	CTG	100;98;99	C;T,G;G	68;64,2;59	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	E90K	NONSYN	268	270	GAA	1180	1182	GAA	107;105;105	G,A;A;A	70,7;77;70	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	0	.	p	.	0	T94P	NONSYN	280	282	ACC	1192	1194	ACC	104;108;108	A,C,G;C,G;C	60,5,2;77,1;78	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1120	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3302	66.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2140	2142	GGC	73;74;74	G;G;C	50;46;48	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1528	1530	GCA	159;162;162	G;C;A	106;108;109	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1531	1533	ATC	163;163;163	A;T;C	111;112;112	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1543	1545	GTG	160;160;160	G;T;G	109;108;109	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1543	1545	GTG	160;160;160	G;T;G	109;108;109	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2047	2049	ACC	88;89;86	A,T;C;C	60,1;65;64	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2101	2103	GCG	75;76;76	G,A;C;G	55,1;50;52	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2101	2103	GCG	75;76;76	G,A;C;G	55,1;50;52	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2224	2226	AGC	86;87;92	A,C;G;C	60,1;62;66	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2233	2235	GGC	84;84;83	G;G;C	59;58;55	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	1140	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2513	86.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2251	2253	CCG	79;79;79	C,G;C,G;G,C,T	51,1;53,1;48,4,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1860	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2967	116.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1451	1453	CCG	102;102;102	C;C;G	66;69;66	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	532	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1978	53.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	611	611	C	55	C	35	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	495	497	GTT	92;85;84	G;T;T	60;55;55	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	G46D	NONSYN	136	138	GGC	498	500	GAC	84;83;84	G;A,C;C	55;54,1;56	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	N121S	NONSYN	361	363	AAC	723	725	AGC	61;63;64	A;G;C	38;40;42	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	726	728	AAA	64;63;65	A,C;A,C;A	42,1;42,1;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	753	755	TAT	67;67;67	T;A;T	44;44;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	N134E	NONSYN	400	402	AAT	762	764	GAG	63;63;64	G;A;G	40;40;39	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	V135L	NONSYN	403	405	GTG	765	767	CTT	64;64;64	C;T;T	41;41;42	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	G140K	NONSYN	418	420	GGA	780	782	AAA	64;64;64	A;A;A	42;42;42	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	789	791	GAA	64;64;64	G;A;A,G	41;39;40,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	813	815	GCA	69;69;68	G;C,A;A	45;42,1;41	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	A196V	NONSYN	586	588	GCC	948	950	GTC	100;100;100	G;T;C,A	64;64;64,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	K207_M208insK	INS	619	619	A	981	981	A	93	A	60	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	A212S	NONSYN	634	636	GCA	999	1001	TCA	109;113;111	T,A;C;A	65,1;68;67	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	574	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1708	66.5	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1116	1116	T	82	T	56	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1920	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4702	77.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	154	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1121	28.7	1	SNP	p	V57M	1	.	.	169	171	ATG	525	527	ATG	40;40;40	A;T;G	29;31;31	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
